GlassScriptPhysician profile
Bijal J Modi
NPI 1285684944
$1,710.67
in general payments reported to CMS, 2019-2025
35 companies · $975 in 2025
The $975 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.84 · 2020: $12.71 · 2021: $38.95 · 2022: $53.93 · 2023: $182 · 2024: $409 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,566.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $156.44 | 2023-2025 | Imfinzi, Enhertu, Lynparza |
| Abbvie INC. | $154.41 | 2019-2025 | |
| Glaxosmithkline, LLC. | $122.03 | 2024-2025 | Jemperli, Zejula, Ojjaara |
| Merck Sharp & Dohme LLC | $112.36 | 2025 | Keytruda, Welireg, Lynparza |
| Daiichi Sankyo INC. | $103.50 | 2024-2025 | Enhertu, Datroway |
| Novartis Pharmaceuticals Corporation | $101.64 | 2019-2025 | |
| Janssen Biotech, INC. | $83.09 | 2023-2025 | Rybrevant, Darzalex, Tecvayli |
| Bayer Healthcare Pharmaceuticals INC. | $80.06 | 2024-2025 | |
| Genzyme Corporation | $64.59 | 2019-2025 | |
| Pfizer INC. | $62.60 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $60.17 | 2020-2025 | Eliquis, Opdivo |
| Tempus Ai, INC | $58.12 | 2024 | |
| Kite Pharma, INC. | $45.27 | 2021-2025 | Yescarta |
| Edwards Lifesciences Corporation | $37.12 | 2025 | Sapien 3 Ultra Resilia |
| Dendreon Pharmaceuticals LLC | $34.57 | 2025 | Provenge |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $34.11 | 2021-2025 | Trodelvy |
| Incyte Corporation | $31.46 | 2023-2024 | Monjuvi, Jakafi |
| Eisai INC. | $28.96 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $27.42 | 2025 | Libtayo |
| Stemline Therapeutics INC. | $24.91 | 2024 | Orserdu |
| Azurity Pharmaceuticals, INC. | $24.71 | 2025 | Danziten |
| Geron Corporation | $24.26 | 2025 | Rytelo |
| Genmab U.S., INC. | $23.68 | 2025 | Epkinly |
| Beigene USA, INC. | $22.10 | 2023 | Brukinsa |
| Adc Therapeutics America, INC. | $22.09 | 2023 | |
| Lilly USA, LLC | $21.54 | 2024 | Verzenio, Jaypirca, Retevmo |
| Astellas Pharma US INC | $20.56 | 2024 | Vyloy |
| Seagen INC. | $19.87 | 2023 | Tukysa |
| Taiho Oncology, INC. | $19.09 | 2025 | |
| Array Biopharma INC | $16.52 | 2025 | Lorbrena, Mektovi, Braftovi |
| Beone Medicines USA, INC. | $15.98 | 2025 | Tevimbra |
| Sobi, INC | $15.07 | 2024 | |
| Celgene Corporation | $14.59 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $13.90 | 2025 | Akynzeo |
| Blueprint Medicines Corporation | $13.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bijal Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.